Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Alzheimer's Disease: Overview01:26

Alzheimer's Disease: Overview

1.7K
Alzheimer's Disease (AD) is a continually advancing neurodegenerative disorder, distinguished by escalating memory loss, cognitive dysfunction, and dementia. The disease unfolds in three stages: preclinical, mild cognitive impairment (MCI), and dementia. Its onset is insidious, and the progression gradual, with the cause not well explained by other disorders.
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
1.7K
Alzheimer's Disease: Treatment01:22

Alzheimer's Disease: Treatment

1.3K
Alzheimer's Disease (AD), a neurodegenerative disorder, is pathologically identified by amyloid plaques and neurofibrillary tangles composed of tau protein. AD pharmacotherapy aims to manage cognitive symptoms, delay disease progression, and treat behavioral symptoms. The treatment is primarily symptomatic and palliative, with no definitive disease-modifying therapy available. Cholinesterase inhibitors, including donepezil (Aricept), rivastigmine (Exelon), and galantamine (Razadyne), are...
1.3K
Alzheimer Disease l: Introduction01:29

Alzheimer Disease l: Introduction

29
Alzheimer disease is a chronic, progressive, and irreversible neurodegenerative disorder and the most common cause of dementia in older adults. It leads to gradual neuronal loss, causing cognitive decline, behavioral changes, and loss of functional independence.Risk Factors and EtiologyThe disease is multifactorial. Age is the strongest risk factor, with prevalence doubling every 5 years after age 65. Genetic factors include mutations in genes such as APP, PSEN1, and PSEN2, which are associated...
29
Alzheimer Disease ll: Pathophysiology01:23

Alzheimer Disease ll: Pathophysiology

42
Alzheimer disease involves structural changes in the brain that begin long before symptoms appear. The most distinctive features are extracellular neuritic plaques and intracellular neurofibrillary tangles.Neuritic plaques form in the cerebral cortex and around blood vessels. These plaques contain a dense core of beta-amyloid (Aβ)—a toxic protein fragment that clumps outside neurons. The core is surrounded by damaged neuronal extensions, as well as reactive astrocytes and...
42
Dementia l: Introduction01:22

Dementia l: Introduction

35
Dementia is an acquired, progressive syndrome characterized by a decline in multiple cognitive domains severe enough to impair daily functioning and reduce independence. Although memory loss is a central feature, the diagnosis requires additional deficits involving language, executive function, visuospatial skills, judgment, calculation, or abstract reasoning. These cognitive impairments reflect underlying neurodegenerative or vascular processes that gradually disrupt neuronal networks...
35

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

A Brain Connectivity Approach to Detect Diffusion-Weighted Imaging Changes in Post-Traumatic Epilepsy.

Bioengineering (Basel, Switzerland)·2026
Same author

Enhancing breath-based diagnostics through eXplainable Artificial Intelligence.

PloS one·2026
Same author

Higher-order synergy-based ranking in transcriptomic communities via latent factors and O-information.

Physics in medicine and biology·2026
Same author

Explainable Bidirectional Long Short-Term Memory Networks Learn Chemistry from SMILES for Predicting Toxicity of Androgen and Estrogen Receptor Chemicals.

ACS omega·2026
Same author

Leveraging AI and multi-source satellite imagery for multi-hazard monitoring and susceptibility mapping in urban areas.

Scientific reports·2026
Same author

Explainable AI-Based Hyperspectral Classification Reveals Differences in Spectral Response over Phenological Stages.

Biology·2026
Same journal

Erratum: Low-dimensional model for adaptive networks of spiking neurons [Phys. Rev. E 111, 014422 (2025)].

Physical review. E·2026
Same journal

Disentangling the effects of many-body forces on depletion interactions.

Physical review. E·2026
Same journal

Charge transport and mode transition in dual-energy electron beam diodes.

Physical review. E·2026
Same journal

Optimization of multisite reactions in complex compartmentalized media.

Physical review. E·2026
Same journal

Origin of geometric cohesion in nonconvex granular materials: Interplay between interdigitation and rotational constraints enhancing frictional stability.

Physical review. E·2026
Same journal

Interaction of walkers with a standing Faraday wave.

Physical review. E·2026
See all related articles

Related Experiment Video

Updated: May 5, 2026

Identification of Disease-related Spatial Covariance Patterns using Neuroimaging Data
14:27

Identification of Disease-related Spatial Covariance Patterns using Neuroimaging Data

Published on: June 26, 2013

15.2K

Exponential random graph-based eXplainable Artificial Intelligence for Alzheimer disease.

Nicola Amoroso1,2, Ester Pantaleo2,3, Marianna La Rocca2,3

  • 1Università degli Studi di Bari Aldo Moro, Dipartimento di Farmacia - Scienze del Farmaco, Bari, Italy.

Physical Review. E
|February 20, 2026
PubMed
Summary
This summary is machine-generated.

Exponential random-graph (ERG) models effectively characterize Alzheimer's disease (AD) impacts on brain connectivity. This statistical physics approach accurately identifies disease patterns and affected brain regions, aiding diagnosis and understanding disease mechanisms.

More Related Videos

Application of Granger Causality Analysis of the Directed Functional Connection in Alzheimer's Disease and Mild Cognitive Impairment
08:43

Application of Granger Causality Analysis of the Directed Functional Connection in Alzheimer's Disease and Mild Cognitive Impairment

Published on: August 7, 2017

7.5K
A Data-Driven Approach to Quantifying Immune States in Sepsis
07:42

A Data-Driven Approach to Quantifying Immune States in Sepsis

Published on: February 7, 2025

598

Related Experiment Videos

Last Updated: May 5, 2026

Identification of Disease-related Spatial Covariance Patterns using Neuroimaging Data
14:27

Identification of Disease-related Spatial Covariance Patterns using Neuroimaging Data

Published on: June 26, 2013

15.2K
Application of Granger Causality Analysis of the Directed Functional Connection in Alzheimer's Disease and Mild Cognitive Impairment
08:43

Application of Granger Causality Analysis of the Directed Functional Connection in Alzheimer's Disease and Mild Cognitive Impairment

Published on: August 7, 2017

7.5K
A Data-Driven Approach to Quantifying Immune States in Sepsis
07:42

A Data-Driven Approach to Quantifying Immune States in Sepsis

Published on: February 7, 2025

598

Area of Science:

  • Statistical physics
  • Network science
  • Neuroimaging

Background:

  • Alzheimer's disease (AD) significantly impacts brain connectivity.
  • Understanding these changes is crucial for diagnosis and treatment.
  • Existing methods may not fully capture complex network alterations.

Purpose of the Study:

  • To apply exponential random-graph (ERG) models to characterize brain connectivity changes in Alzheimer's disease (AD).
  • To assess the efficacy of ERG models in identifying global and local disease patterns.
  • To explore the potential of ERG models for diagnostic support systems.

Main Methods:

  • Utilized T1-weighted magnetic-resonance imaging (MRI) scans from 126 normal controls (NC) and 92 AD patients.
  • Constructed brain connectivity networks where nodes represent brain regions and links represent structural relationships.
  • Applied exponential random-graph (ERG) models to analyze the network data.

Main Results:

  • ERG models successfully outlined both global and local brain connectivity patterns associated with AD.
  • Achieved a high classification accuracy of 0.82±0.08 in distinguishing AD patients from controls.
  • Identified specific brain regions most affected by the disease.

Conclusions:

  • Exponential random-graph (ERG) models are a powerful tool for analyzing brain connectivity alterations in Alzheimer's disease (AD).
  • The approach demonstrates potential for developing innovative diagnosis support systems and understanding disease pathology.
  • The methodology's generality suggests broad applicability to other diseases and data types.